Tagged Articles

Invokana lawsuits 6 articles

Judge rules Invokana lawsuits will stay in federal court

More than a hundred lawsuits waged against Johnson & Johnson’s Janssen Pharmaceuticals alleging the company’s type 2 diabetes drug Invokana caused kidney injuries will stay in federal court after they were removed from state court, a Pennsylvania federal judge ruled. Attorneys representing the 106 plaintiffs had sought to consolidate the cases in Philadelphia Court of Common Pleas, but Janssen removed the cases to federal court under the Class Action Fairness Act. Janssen had asked that the cases ultimately be transferred to New Jersey, where several other Invokana lawsuits are pending. Invokana, known chemically as canagliflozin, was approved by the Food ... Read More

Texas man’s Invokana lawsuit will remain in Pennsylvania state court

A lawsuit filed against a Johnson & Johnson subsidiary in the Philadelphia County Court of Common Pleas by a Texas man will remain in that court system, Judge Denis Cohen ordered, despite the company’s arguments that the lawsuit should be moved out of Pennsylvania state court because the plaintiff lacked sufficient ties to the jurisdiction. Matthew Landes is suing Johnson & Johnson and its subsidiary Janssen Pharmaceuticals, makers of the type 2 diabetes drug Invokana, alleging the medication caused a spike of acids in his blood, a serious condition known as ketoacidosis that can result in coma or death if ... Read More

Plaintiffs attorneys request consolidation of 56 Invokana lawsuits

Attorneys representing patients suing Johnson & Johnson and its subsidiaries alleging kidney injuries with its type 2 diabetes drug Invokana asked a Judicial Panel on Multidistrict Litigation to consolidate into New Jersey federal court 56 lawsuits currently in 11 different federal districts. Leaving them separate, attorneys argued, would be highly inefficient since they largely involve the same discovery, documents and depositions. New Jersey was suggested as the appropriate place for the multidistrict litigation (MDL) to be consolidated since Johnson & Johnson is located in New Brunswick, N.J., and the codefendant, Janssen Pharma, is in neighboring Titusville. Plaintiffs attorneys also argued ... Read More

Plaintiffs suing Invokana makers seek to consolidate litigation

There is more movement in the growing litigation involving injuries allegedly caused by the type 2 diabetes drug Invokana. Plaintiffs with claims pending in the Philadelphia Court of Common Pleas are seeking to consolidate their claims into a mass tort program. Currently, 87 cases are pending in Philadelphia. They are reportedly virtually identical. Consolidating them would cut down on legal costs and increase efficiency. Meanwhile, a motion was filed with the U.S. Judicial Panel on Multidistrict Litigation (MDL) Requesting that federal claims be consolidated into the Trenton Division of the U.S. District Court of the District of New Jersey. At least ... Read More

Janssen files motion to send Invokana lawsuits to courts outside PA

Johnson & Johnson subsidiary Janssen Pharmaceuticals is looking to send Invokana lawsuits piling up in Philadelphia to other courts, starting with a forum non conveniens motion seeking to have plaintiff Joyce Jeffries’ case transferred from the Philadelphia Court of Common Pleas to the plaintiff’s former home state of Tennessee. Jeffries, like dozens of others, have filed lawsuits alleging Janssen did not adequately warn of Invokana side effects including kidney failure and ketoacidosis, a buildup of acid in the blood. Invokana, known chemically as canagliflozin, is in a class of type 2 diabetes medications known as SGLT2 inhibitors. Jeffries’ lawsuit alleges ... Read More

Number of Invokana side effects lawsuits growing in PA

Lawsuits alleging injuries caused by the type 2 diabetes drug Invokana are mounting across the country, but legal experts say they expect a large portion of them to come to Philadelphia because it is the home state of one of the manufacturers. At least 15 lawsuits have been filed in the Philadelphia Court of Common Please since December, court records show. The lawsuits blame Johnson & Johnson’s Janssen Pharmaceuticals and Mitsubishi Tanabe Pharmaceuticals for failing to warn the public of possible risks with Invokana. The lawsuits also claim that the medication is defectively designed because it does not allow the ... Read More